Safety and efficacy of combining ATRA with G-CSF in HSPC mobilization; a pilot study in multiple myeloma and non-Hodgkin's lymphoma patients [1]

Bone Marrow Transplantation

Volumn 40, Issue 8, 2007, Pages 801-803

  Herbert, K E ^a,b   True, S ^a   McArthur, G ^a,b   Prince, H M ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RETINOIC ACID;

ANEMIA; ANOREXIA; ANXIETY; BONE PAIN; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COMMON COLD; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERTRIGLYCERIDEMIA; INJECTION SITE REACTION; KIDNEY DISEASE; LETHARGY; LETTER; MALE; MONITORING; MULTIPLE MYELOMA; NAUSEA; NEUROPATHIC PAIN; NONHODGKIN LYMPHOMA; PERIPHERAL EDEMA; PHASE 1 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; SIDE EFFECT; STEM CELL MOBILIZATION; STOMATITIS; THROMBOCYTOPENIA;

ANTIGENS, CD34; BLOOD PLATELETS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MULTIPLE MYELOMA; PILOT PROJECTS; PLATELET COUNT; TRANSPLANTATION CONDITIONING; TRETINOIN;

EID: 34948826918     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705804     Document Type: Letter

References (10)

1. To LB, Haylocks DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood 1997; 89: 2233-2258.
2. Morgan S, Seymour JF, Grigg A, Matthews JP, Prince HM, Wolf MM et al. Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine. Leukemia 2004; 18: 1034.
3. Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/ progenitor cell mobilization. Blood 2004; 103: 1580-1585.
4. Herbert KE, Walkley CR, Winkler IG, Hendy J, Olsen GH, Yuan YD et al. Granulocyte colony-stimulating factor and an RARalpha specific agonist, VTP195183, synergize to enhance the mobilization of hematopoietic progenitor cells. Transplantation 2007; 83: 375-384.
5. Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell Jr RP. The 'retinoic acid syndrome' in acute promyelocytic leukemia. Ann Intern Med 1992; 117: 292-296.
6. Lindemann A, Herrmann F, Oster W, Haffner G, Meyenburg W, Souza LM et al. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 1989; 74: 2644-2651.
7. Roche. Vesanoid product information. 2004.
8. Dubois C, Schlageter MH, de Gentile A, Guidez F, Balitrand N, Toubert ME et al. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood 1994; 83: 3264-3270.
9. Geiger S, Dombret H, Merle Beral H, Bucherer C, Lacombe C, Lelievre J. Study of microrheological properties of acute promyelocytic leukemia cells during all-trans retinoic acid therapy. Br J Haematol 1994; 87: 9 (abstract, suppl 1).
10. Huttman A, Gutersohn A, Noppeney R, Neumann T, Erbel R, Duhrsen U. Rapid succession of peripheral blood progenitor cell mobilization cycles in patients with chronic heart failure: Effects on the hematopoietic system. Transfusion 2006; 46: 1424-1431.